Methods and compositions for detection of Zika viral infections

US10301689B1 · kind B1 · utility

Assignee

• Theranos IP Company, LLC · US

Inventors

• Chandan Shee · Newark, US
• Jerzy Majka · Foster City, US
• Bernardo Araujo · Mountain View, US
• Ushati Das Chakravarty · Mountain View, US
• Katrina Sullivan-Bibee · Palo Alto, US
• Jerald Sapida · San Leandro, US
• Kristine Salazar · Fremont, US

Key dates

• Filing date: Jul 31, 2017
• Grant date: May 28, 2019
• Expiry date: Jul 31, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q1/701
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).